Back
Grifols SA Vs. Biodexa Pharmaceuticals PLC Industry Stock Comparison
Buy
55
GRFS
Grifols SA
Last Price:
9.48
Seasonality Move:
4.09%
Sell
20
BDRX
Biodexa Pharmaceuticals PLC
Last Price:
3.55
Seasonality Move:
-24.92%
Buy
55
Grifols SA (GRFS)
is a Buy
Is Grifols SA a Buy, Sell or Hold?
- The current Grifols SA [GRFS] share price is $9.47. The Score for GRFS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- GRFS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Biodexa Pharmaceuticals PLC (BDRX)
is a Sell
Is Biodexa Pharmaceuticals PLC a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals PLC [BDRX] share price is $3.62. The Score for BDRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
GRFS Stock Price Chart
What is Grifols SA's stock price today?
-
The Grifols SA share price today is $9.47
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GRFS is experiencing selling pressure, which indicates risk of future bearish movement.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals PLC's stock price today?
-
The Biodexa Pharmaceuticals PLC share price today is $3.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing selling pressure, which indicates risk of future bearish movement.
GRFS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 60.09 | Buy |
| Chaikin Money Flow: | -825191 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.52 - 9.26) | Buy |
| Bollinger Bands (100): | (7.5 - 9.16) | Buy |
BDRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 28.13 | Sell |
| Chaikin Money Flow: | -53327 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.89 - 6.69) | Sell |
| Bollinger Bands (100): | (-0.22 - 4.62) | Buy |
GRFS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.32 | Buy |
| 20-day SMA: | 8.97 | Buy |
| 50-day SMA: | 8.87 | Buy |
| 200-day SMA: | 7.74 | Buy |
| 8-day EMA: | 9.28 | Buy |
| 20-day EMA: | 9.07 | Buy |
| 50-day EMA: | 8.8 | Buy |
| 200-day EMA: | 8.26 | Buy |
BDRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.02 | Sell |
| 20-day SMA: | 5.75 | Sell |
| 50-day SMA: | 3.68 | Sell |
| 200-day SMA: | 1.68 | Buy |
| 8-day EMA: | 4.87 | Sell |
| 20-day EMA: | 5.16 | Sell |
| 50-day EMA: | 4.14 | Sell |
| 200-day EMA: | 12.55 | Sell |
Grifols SA Earnings Growth & GRFS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.44 per share.
Biodexa Pharmaceuticals PLC Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.
Grifols SA Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biodexa Pharmaceuticals PLC Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||